Challenges and perspectives of first-line therapy in patients with diffuse B-cell lymphoma: A review
The neoplasm we refer to as diffuse large B-cell lymphoma (DLBCL) consists of many different subtypes that should not be subject to a single standardized treatment. Critical at the diagnostic stage is the identification of rare (510%) but extremely aggressive variants high grade B-cell lymphomas wi...
Main Authors: | Lali G. Babicheva, Irina V. Poddubnaya |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Habib O.N.
2023-08-01
|
Series: | Современная онкология |
Subjects: | |
Online Access: | https://modernonco.orscience.ru/1815-1434/article/viewFile/568126/133530 |
Similar Items
-
A prognostic model based on gene expression parameters predicts a better response to bortezomib-containing immunochemotherapy in diffuse large B-cell lymphoma
by: Adrián Mosquera Orgueira, et al.
Published: (2023-04-01) -
Do Double-Expressor High-Grade B-Cell Lymphomas Really Need Intensified Treatment? A Report from the Real-Life Series of High-Grade B-Cell Lymphomas Treated with Different Therapeutic Protocols at the Institute of Oncology Ljubljana
by: Lučka Boltežar, et al.
Published: (2024-01-01) -
Primary diffuse large B-cell lymphoma at gastrojejunostomy site: A rare case report
by: Shruthi, et al.
Published: (2023-01-01) -
Downgraded Lymphoma: B-Chronic Lymphocytic Leukemia in a Known Case of Diffuse Large B-Cell Lymphoma - De Novo Occurrence or Transformation
by: Smeeta Gejendra, et al.
Published: (2015-11-01) -
Unspecified skin peripheral T-cell lymphoma: diagnostic difficulties
by: O. Yu. Olisova, et al.
Published: (2020-10-01)